These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1833661)

  • 1. The effects of the competitive NMDA receptor antagonist CPP on the high pressure neurological syndrome in a primate model.
    Pearce PC; Halsey MJ; MacLean CJ; Ward EM; Webster MT; Luff NP; Pearson J; Charlett A; Meldrum BS
    Neuropharmacology; 1991 Jul; 30(7):787-96. PubMed ID: 1833661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the beta carboline abecarnil with the high pressure neurological syndrome in a primate model.
    Pearce PC; Halsey MJ; MacLean CJ; Passingham S; Pearson J; Mehta RL; Meldrum BS; Jordan CJ; Ward EM
    Psychopharmacology (Berl); 1992; 109(1-2):163-71. PubMed ID: 1365651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The orally active NMDA receptor antagonist CGP 39551 ameliorates the high pressure neurological syndrome in Papio anubis.
    Pearce PC; Halsey MJ; Maclean CJ; Ward EM; Pearson J; Henley M; Meldrum BS
    Brain Res; 1993 Sep; 622(1-2):177-84. PubMed ID: 7902190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of MK801 on the high pressure neurological syndrome in the baboon (Papio anubis).
    Pearce PC; Doré CJ; Halsey MJ; Luff NP; Maclean CJ; Meldrum BS
    Neuropharmacology; 1990 Oct; 29(10):931-41. PubMed ID: 2255385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of lamotrigine against HPNS in rodent and primate models.
    Pearce PC; Halsey MJ; Maclean CJ; Ward EM; Shergill HK; Tindley G; Meldrum BS
    Pharmacol Biochem Behav; 1994 May; 48(1):259-63. PubMed ID: 7913227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate interactions with the HPNS: EEG and behavioral observations.
    Pearce PC; Clarke D; Doré CJ; Halsey MJ; Luff NP; Maclean CJ
    Undersea Biomed Res; 1989 Mar; 16(2):99-113. PubMed ID: 2499971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of non-competitive NMDA receptor antagonists on rats exposed to hyperbaric pressure.
    Wardley-Smith B; Wann KT
    Eur J Pharmacol; 1989 Jun; 165(1):107-12. PubMed ID: 2548878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from high pressure induced hyperexcitability by the AMPA/kainate receptor antagonists GYKI 52466 and LY 293558.
    Pearce PC; Maclean CJ; Shergill HK; Ward EM; Halsey MJ; Tindley G; Pearson J; Meldrum BS
    Neuropharmacology; 1994 May; 33(5):605-12. PubMed ID: 7936094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2-aminophosphonoheptanoic acid on the EEG of rats exposed to high pressure.
    Wardley-Smith B; Rostain JC; Meldrum BS; Halsey MJ
    Undersea Biomed Res; 1986 Jun; 13(2):155-63. PubMed ID: 3727181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The competitive NMDA antagonist CPP blocks MK-801-elicited popping behavior in mice.
    Deutsch SI; Rosse RB; Riggs RL; Koetzner L; Mastropaolo J
    Neuropsychopharmacology; 1996 Oct; 15(4):329-31. PubMed ID: 8887986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
    Goettl VM; Larson AA
    Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
    Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
    Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-aminobutyric acid and the high pressure neurological syndrome.
    Rostain JC; Wardley-Smith B; Forni C; Halsey MJ
    Neuropharmacology; 1986 May; 25(5):545-54. PubMed ID: 3090469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist.
    Courteix C; Privat AM; Pélissier T; Hernandez A; Eschalier A; Fialip J
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1237-45. PubMed ID: 17551093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic electroencephalographic studies in a hyperbaric environment--specific reference to high pressure nervous syndrome.
    Okuda S; Matsuoka S; Mohri M
    J UOEH; 1988 Sep; 10(3):247-61. PubMed ID: 3175383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets.
    Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M
    Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of isolated N-methyl-d-aspartate receptor response under hyperbaric conditions.
    Mor A; Grossman Y
    Eur J Neurosci; 2006 Dec; 24(12):3453-62. PubMed ID: 17229094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPP, an NMDA-receptor antagonist, blocks 4-aminopyridine-induced spreading depression episodes but not epileptiform activity in immature rat hippocampal slices.
    Psarropoulou C; Avoli M
    Neurosci Lett; 1992 Jan; 135(1):139-43. PubMed ID: 1347414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons.
    French ED
    Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.